Eyenovia Inc (EYEN)
0.4903
-0.04
(-7.40%)
USD |
NASDAQ |
Oct 31, 16:00
0.494
0.00 (0.00%)
After-Hours: 20:00
Eyenovia Cash from Financing (Quarterly): 2.545M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 2.545M |
| March 31, 2024 | 3.133M |
| December 31, 2023 | 0.6143M |
| September 30, 2023 | 10.78M |
| June 30, 2023 | 5.001M |
| March 31, 2023 | 3.400M |
| December 31, 2022 | 3.307M |
| September 30, 2022 | 2.872M |
| June 30, 2022 | -0.3185M |
| March 31, 2022 | 15.65M |
| December 31, 2021 | 12.29M |
| September 30, 2021 | -0.189M |
| June 30, 2021 | 7.902M |
| March 31, 2021 | 1.453M |
| December 31, 2020 | 0.0974M |
| Date | Value |
|---|---|
| September 30, 2020 | 14.69M |
| June 30, 2020 | 0.5668M |
| March 31, 2020 | 5.515M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 12.96M |
| June 30, 2019 | 0.0679M |
| March 31, 2019 | 0.4839M |
| December 31, 2018 | 2.818M |
| September 30, 2018 | 0.0565M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 24.74M |
| December 31, 2017 | -0.1564M |
| September 30, 2017 | 6.76M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.3185M
Minimum
Jun 2022
15.65M
Maximum
Mar 2022
4.70M
Average
3.133M
Median
Mar 2024
Cash from Financing (Quarterly) Benchmarks
| Reviva Pharmaceuticals Holdings Inc | 2.681M |
| NovaBay Pharmaceuticals Inc | -0.492M |
| Palatin Technologies Inc | 5.991M |
| iBio Inc | 12.99M |
| Theriva Biologics Inc | 1.773M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.174M |
| Cash from Investing (Quarterly) | -0.0457M |
| Free Cash Flow | -32.24M |
| Free Cash Flow Per Share (Quarterly) | -0.1547 |
| Free Cash Flow to Equity (Quarterly) | -7.384M |
| Free Cash Flow Yield | -139.7% |